Literature DB >> 27544223

Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT.

Kota Yokoyama1,2, Etsuko Imabayashi2, Kaoru Sumida1, Daichi Sone1, Yukio Kimura1, Noriko Sato1, Youhei Mukai3, Miho Murata3, Hiroshi Matsuda4.   

Abstract

PURPOSE: For the quantitative assessment of dopamine transporter (DAT) using [123I]FP-CIT single-photon emission computed tomography (SPECT) (DaTscan), anatomic standardization is preferable for achieving objective and user-independent quantification of striatal binding using a volume-of-interest (VOI) template. However, low accumulation of DAT in Parkinson's disease (PD) would lead to a deformation error when using a DaTscan-specific template without any structural information. To avoid this deformation error, we applied computed tomography (CT) data obtained using SPECT/CT equipment to anatomic standardization.
METHODS: We retrospectively analyzed DaTscan images of 130 patients with parkinsonian syndromes (PS), including 80 PD and 50 non-PD patients. First we segmented gray matter from CT images using statistical parametric mapping 12 (SPM12). These gray-matter images were then anatomically standardized using the diffeomorphic anatomical registration using exponentiated Lie algebra (DARTEL) algorithm. Next, DaTscan images were warped with the same parameters used in the CT anatomic standardization. The target striatal VOIs for decreased DAT in PD were generated from the SPM12 group comparison of 20 DaTscan images from each group. We applied these VOIs to DaTscan images of the remaining patients in both groups and calculated the specific binding ratios (SBRs) using nonspecific counts in a reference area. In terms of the differential diagnosis of PD and non-PD groups using SBR, we compared the present method with two other methods, DaTQUANT and DaTView, which have already been released as software programs for the quantitative assessment of DaTscan images.
RESULTS: The SPM12 group comparison showed a significant DAT decrease in PD patients in the bilateral whole striatum. Of the three methods assessed, the present CT-guided method showed the greatest power for discriminating PD and non-PD groups, as it completely separated the two groups.
CONCLUSION: CT-guided anatomic standardization using the DARTEL algorithm is promising for the quantitative assessment of DaTscan images.

Entities:  

Keywords:  Dopamine transporters; Parkinson’s disease; Quantification; SPECT/CT; Statistical parametric mapping; [123I]FP-CIT SPECT

Mesh:

Substances:

Year:  2016        PMID: 27544223     DOI: 10.1007/s00259-016-3496-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  A fast diffeomorphic image registration algorithm.

Authors:  John Ashburner
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

2.  Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

Authors:  J Booij; J B Habraken; P Bergmans; G Tissingh; A Winogrodzka; E C Wolters; A G Janssen; J C Stoof; E A van Royen
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

3.  Multicenter Semiquantitative Evaluation of (123)I-FP-CIT Brain SPECT.

Authors:  Andrea Skanjeti; Giancarlo Castellano; Baldassarre O Elia; Michela Zotta; Francesca Dazzara; Matteo Manfredi; Antonello Galati; Serena Grimaldi; Michele Balma; Riccardo E Pellerito; Valerio Podio
Journal:  J Neuroimaging       Date:  2015-04-29       Impact factor: 2.486

4.  SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?

Authors:  G Gerasimou; D C Costa; E Papanastasiou; S Bostanjiopoulou; M Arnaoutoglou; E Moralidis; T Aggelopoulou; A Gotzamani-Psarrakou
Journal:  Ann Nucl Med       Date:  2012-03-03       Impact factor: 2.668

5.  Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT.

Authors:  Constantin Lapa; Timo S Spehl; Joachim Brumberg; Ioannis U Isaias; Susanne Schlögl; Michael Lassmann; Ken Herrmann; Philipp T Meyer
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

Review 6.  Neuroimaging in Parkinson disease: from research setting to clinical practice.

Authors:  Marios Politis
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

7.  Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio.

Authors:  Livia Tossici-Bolt; Sandra M A Hoffmann; Paul M Kemp; Rajnikant L Mehta; John S Fleming
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-21       Impact factor: 10.057

8.  Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.

Authors:  Jin Su Kim; Hanna Cho; Jae Yong Choi; Seung Ha Lee; Young Hoon Ryu; Chul Hyoung Lyoo; Myung Sik Lee
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

9.  Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease.

Authors:  Etsuko Imabayashi; Hiroshi Matsuda; Takeshi Tabira; Kunimasa Arima; Nobuo Araki; Kenji Ishii; Fumio Yamashita; Takeshi Iwatsubo
Journal:  Brain Behav       Date:  2013-06-30       Impact factor: 2.708

10.  The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.

Authors:  Sven R Suwijn; Caroline Jm van Boheemen; Rob J de Haan; Gerrit Tissingh; Jan Booij; Rob Ma de Bie
Journal:  EJNMMI Res       Date:  2015-03-17       Impact factor: 3.138

View more
  7 in total

1.  Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics.

Authors:  Markus Wenzel; Fausto Milletari; Julia Krüger; Catharina Lange; Michael Schenk; Ivayla Apostolova; Susanne Klutmann; Marcus Ehrenburg; Ralph Buchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-31       Impact factor: 9.236

2.  Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in [123I] FP-CIT single-photon emission computed tomography (DaTscan).

Authors:  Yuichi Wakabayashi; Ryuichi Takahashi; Tomonori Kanda; Feibi Zeng; Munenobu Nogami; Kazunari Ishii; Takamichi Murakami
Journal:  Neurol Sci       Date:  2018-05-10       Impact factor: 3.307

3.  A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.

Authors:  Yu Iwabuchi; Masashi Kameyama; Yohji Matsusaka; Hidetoshi Narimatsu; Masahiro Hashimoto; Morinobu Seki; Daisuke Ito; Hajime Tabuchi; Yoshitake Yamada; Masahiro Jinzaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-03       Impact factor: 9.236

4.  Interpreting 123I-ioflupane dopamine transporter scans using hybrid scores.

Authors:  Kenneth J Nichols; Brandon Chen; Maria B Tomas; Christopher J Palestro
Journal:  Eur J Hybrid Imaging       Date:  2018-05-21

5.  Creation of an anthropomorphic CT head phantom for verification of image segmentation.

Authors:  Robin B Holmes; Ian S Negus; Sophie J Wiltshire; Gareth C Thorne; Peter Young
Journal:  Med Phys       Date:  2020-03-31       Impact factor: 4.071

Review 6.  Two decades of SPECT/CT - the coming of age of a technology: An updated review of literature evidence.

Authors:  Ora Israel; O Pellet; L Biassoni; D De Palma; E Estrada-Lobato; G Gnanasegaran; T Kuwert; C la Fougère; G Mariani; S Massalha; D Paez; F Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-04       Impact factor: 9.236

7.  Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT.

Authors:  Hiroshi Matsuda; Miho Murata; Yohei Mukai; Kazuya Sako; Hidetoshi Ono; Hiroshi Toyama; Yoshitaka Inui; Yasuyuki Taki; Hideo Shimomura; Hiroshi Nagayama; Amane Tateno; Kenjiro Ono; Hidetomo Murakami; Atsushi Kono; Shigeki Hirano; Satoshi Kuwabara; Norihide Maikusa; Masayo Ogawa; Etsuko Imabayashi; Noriko Sato; Harumasa Takano; Jun Hatazawa; Ryosuke Takahashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-24       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.